Serotonin 5- Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases
Author(s) -
Charles D. Nichols
Publication year - 2009
Publication title -
cardiovascular psychiatry and neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 24
eISSN - 2090-0163
pISSN - 2090-0171
DOI - 10.1155/2009/475108
Subject(s) - serotonin , neuroscience , schizophrenia (object oriented programming) , comorbidity , medicine , cognition , receptor , 5 ht receptor , psychology , bioinformatics , psychiatry , biology
There are high levels of comorbidity between neuropsychiatric and cardiovascular disorders. A key molecule central to both cognitive and cardiovascular function is the molecule serotonin. In the brain, serotonin modulates neuronal activity and is actively involved in mediating many cognitive functions and behaviors. In the periphery, serotonin is involved in vasoconstriction, inflammation, and cell growth, among other processes. It is hypothesized that one component of the serotonin system, the 5-HT 2A receptor, is a common and contributing factor underlying aspects of the comorbidity between neuropsychiatric and cardiovascular disorders. Within the brain this receptor participates in processes such as cognition and working memory, been implicated in effective disorders such as schizophrenia, and mediate the primary effects of hallucinogenic drugs. In the periphery, 5-HT 2A receptors have been linked to vasoconstriction and hypertension, and to inflammatory processes that can lead to atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom